ARTICLE | Clinical News
Narcan naloxone regulatory update
November 23, 2015 8:00 AM UTC
FDA approved Narcan naloxone nasal spray for the emergency treatment of known or suspected opioid overdose. Adapt has worldwide rights to develop and commercialize the opioid antagonist nasal spray f...